WallStreetZenWallStreetZen

NYSE: CRI
Carters Inc Stock Forecast, Predictions & Price Target

Analyst price target for CRI

Based on 4 analysts offering 12 month price targets for Carters Inc.
Min Forecast
$64.00-10.38%
Avg Forecast
$75.25+5.38%
Max Forecast
$80.00+12.03%

Should I buy or sell CRI stock?

Based on 4 analysts offering ratings for Carters Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their CRI stock forecasts and price targets.

CRI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-23

1 of 1

Forecast return on equity

Is CRI forecast to generate an efficient return?

Forecast return on assets

Is CRI forecast to generate an efficient return on assets?

CRI revenue forecast

What is CRI's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.0B+1.6%
Avg 2 year Forecast
$3.1B+5.14%
Avg 3 year Forecast
$3.3B+11.63%
CRI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRI revenue growth forecast

How is CRI forecast to perform vs Apparel Retail companies and vs the US market?
Company
2.95%
Industry
5.97%
Market
9.39%
CRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRI vs Apparel Stocks

TickerPricePrice TargetUp/downsideConsensus
CRI$71.41$75.25+5.38%Sell
BOOT$98.61$97.40-1.23%Strong Buy
FL$21.61$25.93+19.99%Hold
BKE$36.68$34.00-7.31%Strong Sell
URBN$37.02$40.00+8.05%Hold

Carters Stock Forecast FAQ

Is Carters Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: CRI) stock is to Sell CRI stock.

Out of 4 analysts, 0 (0%) are recommending CRI as a Strong Buy, 0 (0%) are recommending CRI as a Buy, 3 (75%) are recommending CRI as a Hold, 0 (0%) are recommending CRI as a Sell, and 1 (25%) are recommending CRI as a Strong Sell.

If you're new to stock investing, here's how to buy Carters stock.

What is CRI's revenue growth forecast for 2024-2026?

(NYSE: CRI) Carters's forecast annual revenue growth rate of 2.95% is not forecast to beat the US Apparel Retail industry's average forecast revenue growth rate of 5.97%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Carters's revenue in 2024 is $2,945,594,000.On average, 2 Wall Street analysts forecast CRI's revenue for 2024 to be $109,178,783,852, with the lowest CRI revenue forecast at $108,963,913,101, and the highest CRI revenue forecast at $109,393,654,604. On average, 2 Wall Street analysts forecast CRI's revenue for 2025 to be $112,980,245,088, with the lowest CRI revenue forecast at $111,579,572,336, and the highest CRI revenue forecast at $114,380,917,840.

In 2026, CRI is forecast to generate $119,952,600,336 in revenue, with the lowest revenue forecast at $119,952,600,336 and the highest revenue forecast at $119,952,600,336.

What is CRI's forecast return on assets (ROA) for 2024-2026?

(NYSE: CRI) forecast ROA is N/A, which is lower than the forecast US Apparel Retail industry average of 4.44%.

What is CRI's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CRI price target, the average CRI price target is $75.25, with the highest CRI stock price forecast at $80.00 and the lowest CRI stock price forecast at $64.00.

On average, Wall Street analysts predict that Carters's share price could reach $75.25 by Apr 18, 2025. The average Carters stock price prediction forecasts a potential upside of 5.38% from the current CRI share price of $71.41.

What is CRI's forecast return on equity (ROE) for 2024-2026?

(NYSE: CRI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.